JPMORGAN CHASE & CO

Position in ELDN — Eledon Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in ELDN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$127,304

+$33,786 QoQ

Shares Held

32,311

+6.4% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 159 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. ELDN ranks #259 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$127,304	32,311	+6.4%	Shares	Defined	2026-08-12
2026-03-31	$93,518	30,363	+35.3%	Shares	Defined	2026-05-13
2025-12-31	$33,887	22,442	-1.1%	Shares	Defined	2026-02-11
2025-09-30	$58,769	22,691	-18.1%	Shares	Defined	2025-11-07
2025-06-30	$75,061	27,698	+28454.6%	Shares	Defined	2025-08-12
2024-09-30	$241	97	+6.6%	Shares	Defined	2024-12-26
2024-06-30	$240	91	+62.5%	Shares	Defined	2024-12-26
2024-03-31	$115	56	-94.3%	Shares	Defined	2024-12-26
2023-12-31	$1,782	990	+3707.7%	Shares	Defined	2024-12-26
2023-09-30	$35	26	+30.0%	Shares	Defined	2023-11-14
2021-09-30	$123	20	-69.7%	Shares	Defined	2021-11-12
2021-06-30	$522	66	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.